Shukra Pharmaceuticals Ltd

SHUKRAPHAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹8 cr, stock is ranked 3,506
High RiskStock is 3.63x as volatile as Nifty
59.002.70 (+4.80%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹8 cr, stock is ranked 3,506
High RiskStock is 3.63x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
46.39
PB RatioPB Ratio
0.57
Dividend YieldDiv. Yield
Sector PESector PE
33.21
Sector PBSector PB
4.71
Sector Div YldSctr Div Yld
0.86%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Shukra Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceuticals Products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020215.485.7011.9511.550.520.460.020.19
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnMar 20, 2022

Shukra Pharmaceuticals Ltd - 524632 - Intimation For Meeting Of Independent Director Of The Company To Be Held On 26.03.2022 | Download

Shukra Pharmaceuticals Ltd - 524632 - Intimation For Meeting Of Independent Director Of The Company To Be Held On 26.03.2022 | Download

Cash Dividend 
Ex. DateSep 19, 2019

Final • Div/Share: ₹ 0.5

Cash Dividend 
Ex. DateAug 31, 2018

Final • Div/Share: ₹ 0.5

See all events